Publications (83) Publications in which a researcher has participated

2020

  1. 1-(2′-Bromobenzyl)-6,7-dihydroxy- N-methyl-tetrahydroisoquinoline and 1,2-Demethyl-nuciferine as Agonists in Human D2 Dopamine Receptors

    Journal of Natural Products, Vol. 83, Núm. 1, pp. 127-133

  2. 2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: In Vivo Evaluation in a Murine Model of Acute Pancreatitis

    Journal of medicinal chemistry, Vol. 63, Núm. 17, pp. 9237-9257

  3. 3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease

    Biomedicines, Vol. 8, Núm. 12, pp. 1-19

  4. A Comprehensive Tyrosine Phosphoproteomic Analysis Reveals Novel Components of the Platelet CLEC-2 Signaling Cascade

    Thrombosis and Haemostasis, Vol. 120, Núm. 2, pp. 262-276

  5. A case of severe hypothermia following three-month administration of paliperidone palmitate: a case report

    Actas espanolas de psiquiatria, Vol. 48, Núm. 4, pp. 181-190

  6. A multicentre prospective study evaluating the impact of proton-pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations

    British Journal of Clinical Pharmacology, Vol. 86, Núm. 8, pp. 1661-1666

  7. A novel NMDA receptor antagonist protects against cognitive decline presented by senescent mice

    Pharmaceutics, Vol. 12, Núm. 3

  8. Advanced nanomedicine characterization by DLS and AF4-UV-MALS: Application to a HIV nanovaccine

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 179

  9. An In Situ Hyaluronic Acid-Fibrin Hydrogel Containing Drug-Loaded Nanocapsules for Intra-Articular Treatment of Inflammatory Joint Diseases

    Regenerative Engineering and Translational Medicine, Vol. 6, Núm. 2, pp. 201-216

  10. Anti-VEGF treatment and response in age-related macular degeneration: Disease’s susceptibility, pharmacogenetics and pharmacokinetics

    Current Medicinal Chemistry, Vol. 27, Núm. 4, pp. 549-569

  11. Antirhea borbonica aqueous extract protects albumin and erythrocytes from glycoxidative damages

    Antioxidants, Vol. 9, Núm. 5

  12. Aportación de esketamina intranasal (Spravato®) en el tratamiento de la depresión mayor resistente

    El Farmacéutico. Hospitales, Núm. 219, pp. 13-19

  13. Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors

    Frontiers in Immunology, Vol. 11

  14. Atención farmacéutica al paciente externo durante la pandemia COVID-19. Telefarmacia

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 44, Núm. 7, pp. 61-65

  15. Atrapadores de glutamato plasmático en ictus isquémico

    Actualidad en farmacología y terapéutica, Vol. 18, Núm. 1, pp. 16-21

  16. Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease

    Journal of Medicinal Chemistry, Vol. 63, Núm. 7, pp. 3610-3633

  17. Biological Activities of Cyclic and Acyclic B-Type Laxaphycins in SH-SY5Y Human Neuroblastoma Cells

    Marine Drugs, Vol. 18, Núm. 7

  18. Características clínicas, manejo y resultados de los pacientes con endoftalmitis estéril asociados con la inyección intravítrea de factores de crecimiento endotelial antivascular

    Archivos de la Sociedad Española de Oftalmologia, Vol. 95, Núm. 5, pp. 211-216

  19. Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6

    Journal of Medicinal Chemistry, Vol. 63, Núm. 17, pp. 9360-9390

  20. Cervico-Vaginal Inflammatory Cytokine and Chemokine Responses to Two Different SIV Immunogens

    Frontiers in Immunology, Vol. 11